Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Spinal Muscular Atrophies of Childhood

• A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
• Clinical Trial to Evaluate the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy Type I
• Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX
• Phase 3 Active Treatment Trial to Evaluate the Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Who Are Being Treated With Nusinersen or Risdiplam
• SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4
• Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3
• Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.
• CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I
• A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
• A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients
• Pilot Study of Growth Hormon to Treat SMA Typ II and III
• Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
• Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I